Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner SYDNEY, Oct. 27, 2025 /PRNewswire/ — Kazia Therapeutics Limited ("Kazia" or the… CISION PRNewswireOctober 27, 2025
ISX Financial EU PLC Appoints Group CFO Ajay Treon to the Board of Directors as Executive Director NICOSIA, Cyprus, Oct. 27, 2025 /PRNewswire/ — ISX Financial EU Plc ("ISXX"),… CISION PRNewswireOctober 27, 2025
Press Release Iridium Unveils Revolutionary Global GPS Device Protection on a Chip Devices reliant on GPS and other Global Navigation Satellite Systems (GNSS) can… CISION PRNewswireOctober 27, 2025
China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392) Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous… CISION PRNewswireOctober 27, 2025
Press Release Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of… CISION PRNewswireOctober 27, 2025
JinkoSolar Supplied Modules to Trinity Energy for Costco Warehouse in Washington State CAMPBELL, Calif., Oct. 27, 2025 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (the "Company,"… CISION PRNewswireOctober 27, 2025
Press Release uSMART Opens Second Branch at Somerset, Broadening Access to Retail Investors with Its New Wealth Management Hub SINGAPORE, Oct. 27, 2025 /PRNewswire/ — On 24 October 2025, uSMART Securities… CISION PRNewswireOctober 27, 2025
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025 -Multiple posters being presented on Ascletis’ small molecule and peptide obesity programs… CISION PRNewswireOctober 27, 2025
